Inno Medicine
Latest round
- Series D
Last raised
- Sep 2026
Total raised
- $119M
Investors
- 11
About Inno Medicine
, dba Inno Medicine, is a pharmaceutical company engaged in the research, development, and manufacturing of novel, precision-targeted drugs. The company has a production base in Shanghai. Qian Ma, the company's founder and CEO, is an expert physician at Beijing Anzhen Hospital Affiliated to Capital Medical University. In 2024, "YN002", the company's pipeline for identifying high risk plaque obtained FDA IND approval. Inno Medicine focuses on targeted drugs, having developed multiple pipelines including "YN001" for the treatment of atherosclerotic cardiovascular disease (ASCVD), "YN002" for identifying high risk plaque, and "YN003" for the treatment of glioma and brain metastasis. The company generates revenue by providing targeted drugs in the fields of cardiovascular and tumor.
Who invested in Inno Medicine
11 investors across 1 round
See all investors in Inno Medicine
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series D
Sep 8, 2026
Amount
$119M
Investors
Questions about Inno Medicine
Who invested in Inno Medicine?
Inno Medicine has 11 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Inno Medicine raised?
Inno Medicine has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Inno Medicine last raise money?
Inno Medicine's most recent round on record is a Series D, in Sep 2026.
What does Inno Medicine do?
, dba Inno Medicine, is a pharmaceutical company engaged in the research, development, and manufacturing of novel, precision-targeted drugs.
Where is Inno Medicine headquartered?
Inno Medicine is headquartered in Beijing, China.
Which VCs invest in companies like Inno Medicine?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back pharmaceuticals companies at Inno Medicine's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series D
Raising like Inno Medicine? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.